100-512 human AB serum
Ended Awarded
- Contract number
- HHSN261NCH55871
- Awardee
-
Gemini Bioproducts LLC UEI TPLGWKT6AM88
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,336
Award facts
- Contract value
-
- $9,336.12 Current, with exercised options
- $0.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Not on record Potential, with all options
- Funding agency
- Office of the Director National Institutes of Health, Department of Health and Human Services
- NAICS code
- 621511 Medical Laboratories
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 0 offers Simplified Acquisition
- Pricing
- Other
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN261NCH55871?
HHSN261NCH55871 was awarded to Gemini Bioproducts LLC by National Cancer Institute (National Institutes of Health) on December 4, 2006.
How much is contract HHSN261NCH55871 worth?
The government has obligated $9,336 on HHSN261NCH55871.
Which agency awarded contract HHSN261NCH55871?
National Cancer Institute (National Institutes of Health) awarded HHSN261NCH55871, with funding from Office of the Director (National Institutes of Health).
Is contract HHSN261NCH55871 an order under another contract?
Yes. HHSN261NCH55871 is a BPA call under HHSN263199700048255B, a blanket purchase agreement.
Was contract HHSN261NCH55871 competed?
The extent of competition for HHSN261NCH55871 was full and open competition. The government received 0 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award